Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

XKON/341170 stock hub

XKON/341170 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/341170is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.8B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/341170

In the news

Latest news · XKON/341170

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/341170 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

136

Groups with data

Currency

KRW

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	26
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 18.8B
Price	KRW 1,787
Price currency	KRW
Rev Per Employee	38,461,538.46x
Sic	2834
Symbol	xkon/341170
Website	https://www.futuremedicine.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-71.01%
FCF yield	-38.28%
P/B ratio	2.89x
P/S ratio	18.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	KRW 1B
Net Income	KRW -13.4B
Pretax Margin	-1,336.67%
Profit Per Employee	KRW -514.1M
ROCE	-100.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-0.45%
Cagr3y	-33.9%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	KRW 7.7B
Cash	KRW 5.4B
Current Assets	KRW 5.8B
Current Liabilities	KRW 604.2M
Debt	KRW 226.3M
Debt Equity	KRW 0.03
Debt FCF	KRW -0.03
Equity	KRW 6.5B
Interest Coverage	-4.55
Liabilities	KRW 1.1B
Long Term Assets	KRW 1.9B
Long Term Liabilities	KRW 537.8M
Net Cash	KRW 5.2B
Net Cash By Market Cap	KRW 27.54
Net Debt Equity	KRW -0.79
Tangible Book Value	KRW 6B
Tangible Book Value Per Share	KRW 642
WACC	10.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.62
Net Working Capital	KRW -49.3M
Quick ratio	9.08
Working Capital	KRW 5.2B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-0.45%
200-day SMA	1,755.1
3Y total return	-71.13%
50-day SMA	1,795
50-day SMA vs 200-day SMA	50over200
All Time High	11,400
All Time High Change	-84.32%
All Time High Date	2022-07-27
All Time Low	680
All Time Low Change	162.79%
All Time Low Date	2025-03-20
ATR	245.3
Beta	-0.1
Beta1y	-0.66
Beta2y	0.72
Ch YTD	-42.35
High	1,787
High52	3,300
High52 Date	2025-12-30
High52ch	-45.85%
Low	1,780
Low52	714
Low52 Date	2025-11-24
Low52ch	150.28%
Ma50ch	-0.45%
Price vs 200-day SMA	1.82%
RSI	46.11
RSI Monthly	43.99
RSI Weekly	49.58
Sharpe ratio	0.55x
Sortino ratio	0.87
Tr YTD	-42.35
Tr1m	-14.7%
Tr1w	3.84%
Tr3m	7.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -7.1B
Operating margin	-708.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,665,691%
Net Borrowing	-186,005,560
Shares Insiders	8.24%
Shares Out	10,533,205
Shares Qo Q	35.88%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -7.7B
Average Volume	7,951.5x
Bv Per Share	703.1
CAPEX	KRW -110.7M
Ch1m	-14.7
Ch1w	3.84
Ch1y	-0.45
Ch3m	7.01
Ch3y	-71.13
Ch6m	67.17
Change	0%
Change From Open	0
Close	1,787
Days Gap	0
Depreciation Amortization	447,276,000
Dollar Volume	664,764
EBIT	KRW -7.1B
EBITDA	KRW -6.6B
EPS	KRW -1,637
F Score	1
FCF	KRW -7.2B
FCF Per Share	KRW -684
Financing CF	-186,005,550
Fiscal Year End	December
Founded	2,015
Investing CF	6,387,616,300
Is Primary Listing	1
Last Report Date	2022-03-31
Ma150	1,738.9
Ma150ch	2.76%
Ma20	1,944.4
Ma20ch	-8.1%
Net CF	-856,578,480
Open	1,787
Position In Range	100
Ppne	599,929,960
Price Date	2026-05-08
Ptbv Ratio	3.16
Relative Volume	0.05x
Revenue	1,000,000,000x
SBC By Revenue	45.53x
Share Based Comp	455,328,000
Tr6m	67.17%
Volume	372
Z Score	-10.89

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/341170 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/341170 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/341170?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+8.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/341170 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.1

Neutral momentum band

Price vs 200-day MA

+1.8%

50/200-day relationship not available

Beta (5Y)

-0.10

Less volatile than the market

Sharpe ratio

0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/341170

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/341170 stock rating?

xkon/341170 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/341170 analysis?

The full report lives at /stocks/xkon/341170/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/341170?

The latest report frames xkon/341170 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/341170 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.